Comparison of a Single Use (Ambu aScope) and a Reusable Flexible Optical Scope for Intubation Through a Supraglottic Airway Device (Aura-i)

NCT ID: NCT02002364

Last Updated: 2014-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patient who are predicted to be difficult to intubate with a standard direct laryngoscope well use flexible optical intubation via a supraglottic airway devise (the Ambu Aura-i). Patients are randomly assigner to a single- or a multiple- use flexible optical scope.

We hypothesize that intubation is obtained equally effective with both types of flexible scopes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single use flexible optical scope

Single use flexible optical scope , Ambu aScope

Group Type ACTIVE_COMPARATOR

tracheal intubation

Intervention Type PROCEDURE

Multiple use flexible optical scope

Multiple use flexible optical scope

Group Type ACTIVE_COMPARATOR

tracheal intubation

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

tracheal intubation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA physical status 1-3 and evaluated pre-operatively and found suitable for tracheal intubation with a flexible optical scope via the SAD and scheduled for elective surgery/anesthesia and are conscious about their rights and consequences of participating in the study.
* The patient must have one or two of the following predictors of difficult tracheal intubation:

1. Modified Mallampati score \> 2 (= "no parts of the Uvula is visible")
2. a thyromental distance of less then or equal to 6.5 cms
3. Combined movement in head and neck \< 90 degrees
4. Mouth-opening less the 4 cm (but must be larger then 2.5 cm)
5. Inability to protrude the teeth n the lower jaw beyond the upper incisors
6. BMI \> 40 combined with a neck-circumference \> 43 cms
7. Upper-lip-bite-test \> 2
8. Previous difficult intubation or laryngoscopy (If more then two criteria are fulfilled the patient should be considered intubated awake instead. . But the upper-lip-bite-test and the prognation-beyond the incisors test represents a similar thing, namely the inability to sub-luxate the lower jaw, the if both these findings are positive it is only considered as counting for one.

Exclusion Criteria

* ASA physical status 4 or 5
* contraindications for use of the SAD
* Patients in whom intubation via a SAD has previously failed
* Patients at risk of aspiration from the gastrointestinal channel
* diseases in mouth, pharynx or larynx that precludes the use of a SAD
* Patients in whom the cricothyroid membrane cannot be localized preanaesthetically
* Patients in whom the doctor making the pre-anaesthetic evaluation finds in need of an awake intubation
* Patients with possible Creutzfeldt-Jacobs disease or contraindication against the use of non-autoclavable equipment r risk of cross contamination with prions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ambu A/S

INDUSTRY

Sponsor Role collaborator

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Michael Seltz Kristensen

Consultant anaesthetist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael S Kristensen

Role: PRINCIPAL_INVESTIGATOR

Rigshospitalet, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rigshospitalet, Denmark

Copenhagen, , Denmark

Site Status RECRUITING

Service d'anesthesie-reanimation 1 avenue Moliere Hopiatl de Hautepierre

Strasbourg, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael S Kristensen, M.D.

Role: CONTACT

0045 35458033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michael S Kristensen, M.D.

Role: primary

0045 3445 8033

Pierre Diemunsch, M.D.

Role: primary

0033 3 88 12 70 76

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Journal nr. H-3-2012-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.